Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,822 | 33,038 | 29,481 | 31,902 | 66,945 |
| Marketable Securities | 58,174 | 55,889 | 49,473 | 49,864 | 21,635 |
| Receivables | 13,057 | 7,953 | 10,842 | 10,060 | 9,167 |
| Inventories | 32,834 | 30,155 | 27,825 | 27,690 | 27,566 |
| TOTAL | $133,222 | $136,561 | $126,566 | $125,432 | $131,129 |
| Non-Current Assets | |||||
| PPE Net | 14,504 | 14,713 | 11,101 | 7,665 | 6,605 |
| Investments And Advances | 30,499 | 31,250 | 19,444 | 18,471 | 20,050 |
| Intangibles | 212,519 | 212,844 | 219,754 | 220,453 | 221,161 |
| Other Non-Current Assets | 10,162 | 10,516 | 15,216 | 15,219 | 16,196 |
| TOTAL | $267,684 | $269,323 | $265,515 | $261,808 | $264,012 |
| Total Assets | $400,906 | $405,884 | $392,081 | $387,240 | $395,141 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,499 | 4,997 | 7,492 | 10,051 | 10,449 |
| Accounts payable and accrued liabilities | 3,750 | 1,486 | 2,890 | 3,209 | 3,297 |
| Accrued Expenses | 7,575 | 11,974 | 10,905 | 9,311 | 8,213 |
| Other current liabilities | 2,113 | 2,279 | 3,681 | 3,575 | 3,929 |
| TOTAL | $18,253 | $22,979 | $27,146 | $28,312 | $27,723 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 0 | N/A | 2,499 |
| Other Non-Current Liabilities | 10,225 | 10,828 | 11,007 | 11,598 | 12,165 |
| TOTAL | $10,423 | $11,017 | $11,196 | $11,773 | $14,794 |
| Total Liabilities | $28,676 | $33,996 | $38,342 | $40,085 | $42,517 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,857 | 48,300 | 48,148 | 47,905 | 47,561 |
| Common Shares | 49 | 48 | 48 | 48 | 48 |
| Retained earnings | -338,510 | -339,696 | -350,766 | -351,387 | -335,549 |
| Other shareholders' equity | -120 | 132 | 130 | 71 | 33 |
| TOTAL | $372,230 | $371,888 | $353,739 | $347,155 | $352,624 |
| Total Liabilities And Equity | $400,906 | $405,884 | $392,081 | $387,240 | $395,141 |